Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bearish
United States Health Care
Biopharma Week in Review - December 2, 2024
Thematic (Sector/Industry)
247 Views
03 Dec 2024 00:10
Issuer-paid
The short holiday week saw another controversial name picked for NIH head, PSTX was acquired by RHHBY, AMGN underwhelmed with obesity data
What is covered in the Full Insight:
Introduction to Biopharma Events
Amgen's Obesity Data Analysis
Medicare's Obesity Drug Proposal
Sarepta and Arrowhead Asset Acquisition
Critical Regulatory Updates
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 10-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Asia ECM
South Korea
Equity Bottom-Up
Japan
Event-Driven
Sell / Short Ideas
Asia Event-Driven
Singapore REITs
Philippines
Trending Insights
More »
HSCI Index Rebalance Preview and Stock Connect (Sep 2025): Plenty of Recent IPOs Could Be Added
Ohayo Japan | Vietnam Trade Deal Boosts Stocks
NTT DC REIT IPO - Decent Yield, Strong Local Backing, a Few Issues
Taishin (2887 TT)/Shin Kong (2888 TT) Merger: Index Flows in July
Geek+ IPO (2590.HK): Long-Term, Warehouse Automation Story, But IPO Valuation Is Not Cheap
Top Unpaywalled Insights
More »
[IO Technicals 2025/26] Bearish Momentum Intensifies
"The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
Overview# 29- The Hard-Asset Reset: Buying the Pullback in Commodities
Discussions
(Paid Plans Only)
Insight Stream
Biopharma Week in Review - December 2, 2024
03 Dec 2024
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.7
x